Douglas Pharmaceuticals is New Zealand’s largest family-owned healthcare company and was founded in 1967 by pharmacist Sir Graeme Douglas. Its mission is to improve lives by providing innovative, competitive, and high-quality healthcare solutions.

The company’s core business is producing prescription drugs for various therapy areas including oncology, dermatology, the central nervous system, and immunology. Douglas develops, manufactures, and distributes specialty generic products, with a preference for those where there are technical or clinical complexities.

The business also focuses on drug repurposing for global markets, seeking to address serious unmet medical needs using medicines approved by the FDA for other indications.